Genpact's AI Mix Shift Is Real-But 25% ATS Growth Must Keep Beating Headwinds

Genpact's AI-led mix shift is visible in the numbers

Genpact's strategic pivot is no longer just a narrative. In Q2, ATS grew 24.1% and reached 27% of total net revenues. Investors are no longer looking at a vague AI story; Genpact is already selling a materially larger share of a faster-growing part of the business.

Why the stock still has to earn a higher valuation

The market is still not fully convinced. The shares have fallen 9.4% since the earnings release on May 7, a reaction tied to softer second-quarter revenue guidance. In other words, investors acknowledged the strategic shift but remained uneasy about near-term top-line momentum.

That makes the next few quarters important. Management reported record bookings, an increasing backlog, and continued pipeline growth, while also saying it now expects ATS revenue to grow at least 25% for the full year. If ATS can keep offsetting the drag from slower legacy work, the stock has room to be reassessed. If momentum fades, this risks looking like a strong quarter rather than a durable re-rating.

The margin profile shows why the mix shift matters

Better revenue mix is starting to show up in earnings power

This quarter matters because the higher-value mix is beginning to show up in the metrics investors actually cash. In Q2, Advanced Technology Solutions net revenues grew 24.1% and accounted for 27% of total net revenues, while Core Business Services grew just 1.9%. Even with only 7.1% overall net revenue growth, adjusted diluted EPS increased 13.6% to $1.00. That suggests Genpact is generating more earnings power from each sales dollar as the mix shifts toward higher-value work.

The margin trend points in the same direction. Gross margin reached 36.5%, and management had already flagged the same pattern in Q1, when it highlighted another quarter of year-over-year margin expansion. The company now points to 13 consecutive quarters of gross margin expansion. Put simply, Genpact is improving quality mix, not just adding volume.

The bull case does not require instant double-digit total growth

The bullish case is straightforward: if ATS keeps growing faster than the rest of the business, total revenue can stay moderately healthy while earnings power improves. That is usually how a mixed service company begins to earn a better valuation.

The counterpoint is that Genpact is also walking away from lower-value content management and commoditized contact-center work. Management has said that transition could reduce 2026 revenue growth by nearly two percentage points. So the real test is whether the higher-value mix can keep compounding even as the company gives up some lower-end volume.

What to watch over the next few quarters

• Whether ATS growth remains close to or above the new full-year guide of at least 25%.
• Whether gross margin and EPS growth continue to expand as the mix shifts.
• Whether weaker second-half revenue from exiting lower-value work is offset by bookings and backlog conversion.

The debate now is durability, not whether the strategy exists

With ATS already at 27% of total net revenues and management guiding to at least 25% ATS growth for the year, the question is no longer whether Genpact has an AI-led strategy. The real debate is whether those wins are building a more durable, higher-quality revenue base-or merely masking the growth drag from leaving behind commoditized work.

Why bulls think the demand signal looks sturdier this time

Bulls have a reasonable case because demand is showing up in several places at once. Genpact says it has secured more than $1 billion in 2026 Agentic bookings and signed 12 large deals in the first half, double the pace of last year. That matters because ATS is not just a software upsell; it points to broader customer conversations around process ownership and transformation.

The stock's recent performance also leaves room for optimism. Shares are down about 9.6% since the beginning of the year in one recent snapshot, while other recent coverage suggests a much softer year for the stock overall. Investors are not paying up for a perfect outcome; they are judging whether a still-growing but still relatively small part of the business can do over time what the legacy portfolio cannot.

Why a strong pipeline is not the same as proof

The caution is practical. Genpact is leaving behind lower-value work expected to cut 2026 revenue growth by nearly two percentage points, with much of the impact concentrated in the second half. That means mix quality can improve before total growth looks clean.

There is also a basic checkpoint: strong bookings mean less if margin expansion and earnings growth stall. Bulls need the economics to keep doing what they have been doing, not just the pipeline headlines.

What would settle the argument next quarter

What investors really need to see is not another strategic slogan. They need evidence that demand is converting into booked revenue and profit without losing the margin benefit that has supported the story so far.